S&P 500 (NYSE:SPY) component Davita, Inc. (NYSE:DVA) reported its results for the first quarter. Davita, Inc. operates kidney dialysis centers and provides related lab and ancillary services across the United States.
Davita Earnings Cheat Sheet for the First Quarter
Results: Net income for the specialized health services company company fell to $94.5 million (96 cents/share) vs. $109.4 million ($1.04/share) a year earlier. A decline of 13.6% from the year earlier quarter.
Revenue: Rose 3% to $1.61 billion YoY.
Actual vs. Wall St. Expectations: DVA fell in line with the mean analyst estimate of 96 cents/share. Estimates ranged from 81 cents per share to $1.22 per share.
Key Stats: The company has now seen net income fall in each of the last two quarters. In the fourth quarter of the last fiscal year, net income fell 37.1% from the year earlier quarter.
Over the last five quarters, revenue has increased 5.1% on average year over year. The biggest increase came in the first quarter of the last fiscal year, when revenue rose 7.7% from the year earlier quarter.
Competitors to Watch: Fresenius Medical Care AG & Co. (NYSE:FMS), Hanger Orthopedic Group, Inc. (NYSE:HGR), Continucare Corporation (NYSE:CNU), Universal Health Services, Inc. (NYSE:UHS), NovaMed, Inc. (NASDAQ:NOVA), MedCath Corporation (NASDAQ:MDTH), Dynacq Healthcare, Inc. (NASDAQ:DYII), and U.S. Physical Therapy, Inc. (NASDAQ:USPH)
Stock Performance: Shares of DVA are unchanged in pre-market trading.